258 related articles for article (PubMed ID: 30366937)
1. Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy.
Jiang S; Eberhart CG; Lim M; Heo HY; Zhang Y; Blair L; Wen Z; Holdhoff M; Lin D; Huang P; Qin H; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
Clin Cancer Res; 2019 Jan; 25(2):552-561. PubMed ID: 30366937
[TBL] [Abstract][Full Text] [Related]
2. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
[TBL] [Abstract][Full Text] [Related]
3. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.
Ma B; Blakeley JO; Hong X; Zhang H; Jiang S; Blair L; Zhang Y; Heo HY; Zhang M; van Zijl PC; Zhou J
J Magn Reson Imaging; 2016 Aug; 44(2):456-62. PubMed ID: 26788865
[TBL] [Abstract][Full Text] [Related]
4. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
[TBL] [Abstract][Full Text] [Related]
5. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
Durmo F; Rydhög A; Testud F; Lätt J; Schmitt B; Rydelius A; Englund E; Bengzon J; van Zijl P; Knutsson L; Sundgren PC
PLoS One; 2020; 15(12):e0244003. PubMed ID: 33373375
[TBL] [Abstract][Full Text] [Related]
7. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
[TBL] [Abstract][Full Text] [Related]
8. Repeatability of amide proton transfer-weighted signals in the brain according to clinical condition and anatomical location.
Lee JB; Park JE; Jung SC; Jo Y; Kim D; Kim HS; Choi CG; Kim SJ; Kang DW
Eur Radiol; 2020 Jan; 30(1):346-356. PubMed ID: 31338651
[TBL] [Abstract][Full Text] [Related]
9. Radiomics analysis of amide proton transfer-weighted and structural MR images for treatment response assessment in malignant gliomas.
Jiang S; Guo P; Heo HY; Zhang Y; Wu J; Jin Y; Laterra J; Eberhart CG; Lim M; Blakeley JO
NMR Biomed; 2023 Jan; 36(1):e4824. PubMed ID: 36057449
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
[TBL] [Abstract][Full Text] [Related]
11. Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients.
Guo P; Unberath M; Heo HY; Eberhart CG; Lim M; Blakeley JO; Jiang S
Neuroimage Clin; 2022; 35():103121. PubMed ID: 35905666
[TBL] [Abstract][Full Text] [Related]
12. Predicting O6-Methylguanine-DNA Methyltransferase Protein Expression in Primary Low- and High-Grade Gliomas Using Certain Qualitative Characteristics of Amide Proton Transfer-Weighted Magnetic Resonance Imaging.
Su L; Gao P; Lin S; Wu B; Qin W; Lin Y; Xue J
World Neurosurg; 2018 Aug; 116():e814-e823. PubMed ID: 29803064
[TBL] [Abstract][Full Text] [Related]
13. Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics.
Zhuo Z; Qu L; Zhang P; Duan Y; Cheng D; Xu X; Sun T; Ding J; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4426-4436. PubMed ID: 34131804
[TBL] [Abstract][Full Text] [Related]
14. Amide proton transfer-weighted imaging of pediatric brainstem glioma and its predicted value for H3 K27 alteration.
Cheng D; Zhuo Z; Zhang P; Qu L; Duan Y; Xu X; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
Acta Radiol; 2023 Nov; 64(11):2922-2930. PubMed ID: 37722801
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Glioma Response to Radiotherapy Using Multiple MRI Biomarkers with Manual and Semiautomated Segmentation Algorithms.
Yu Y; Lee DH; Peng SL; Zhang K; Zhang Y; Jiang S; Zhao X; Heo HY; Wang X; Chen M; Lu H; Li H; Zhou J
J Neuroimaging; 2016 Nov; 26(6):626-634. PubMed ID: 27128445
[TBL] [Abstract][Full Text] [Related]
16. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.
Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS
Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352
[TBL] [Abstract][Full Text] [Related]
17. Amide proton transfer weighted imaging in pediatric neuro-oncology: initial experience.
Obdeijn IV; Wiegers EC; Alic L; Plasschaert SLA; Kranendonk MEG; Hoogduin HM; Klomp DWJ; Wijnen JP; Lequin MH
NMR Biomed; 2024 Jun; 37(6):e5122. PubMed ID: 38369653
[TBL] [Abstract][Full Text] [Related]
18. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
[TBL] [Abstract][Full Text] [Related]
19. CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas.
Huang Q; Wu J; Le N; Shen Y; Guo P; Schreck KC; Kamson D; Blair L; Heo HY; Li X; Li W; Sair HL; Blakeley JO; Laterra J; Holdhoff M; Grossman SA; Mukherjee D; Bettegowda C; van Zijl P; Zhou J; Jiang S
Magn Reson Imaging; 2023 Oct; 102():222-228. PubMed ID: 37321378
[TBL] [Abstract][Full Text] [Related]
20. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.
Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR
Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
